$46.67
-0.12-0.26%
Pre-Market: 5:41 PM EDT
15 minutes delayed
CRISPR Therapeutics Stock (NASDAQ: CRSP) stock price, news, charts, stock research, profile.
You can purchase shares of CRISPR Therapeutics (NASDAQ:CRSP) through any online brokerage.
There are no as such competitors for CRISPR Therapeutics.
CRISPR Therapeutics has a consensus price target of $74.40.
The stock price for CRISPR Therapeutics (NASDAQ: CRSP) is $46.67 last updated September 24, 2024 at 5:41 PM EDT.
There are no upcoming dividends for CRISPR Therapeutics.
CRISPR Therapeutics’s Q3 earnings are confirmed for Monday, November 4, 2024.
There is no upcoming split for CRISPR Therapeutics.
CRISPR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.